Clinical Trial Update: Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study by Brii Biosciences evaluating the safety and efficacy of BRII-835 and BRII-179 combination therapy for chron…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• BRII-179
• BRII-835

Snippet

Sponsor: Brii Biosciences Limited | Conditions: Hepatitis B, Chronic | Phase 2 | Status: COMPLETED